Ross Barrett, Cancer Focus Fund II, LP

Ross Barrett, Managing Partner of Cancer Focus Fund II, LP, invests exclusively in global cancer companies at the late preclinical. See contact routes.

About Ross Barrett

Ross Barrett, Managing Partner of Cancer Focus Fund II, LP, invests exclusively in global cancer companies at the late preclinical through Phase I/II clinical trial stages, focusing on cell therapy, immunotherapy, targeted therapies, and radio-therapeutics. His distinctive thesis leverages a unique partnership with MD Anderson Cancer Center to fund first-in-class drugs ready for clinical evaluation at the world’s largest oncology trials program. Notable portfolio investments include $4.5 million in ImmunoGenesis for a solid tumor trial and $4.5 million in Eisbach for a Phase 1/2 study of EIS-12656, alongside support for KAHR’s anti-CD47 candidate in blood cancers.

Ross Barrett at a glance

Role
Related Person
Organization
Cancer Focus Fund II, LP
Location
Shreveport
Investor type
Individual/Angel

Frequently asked about Ross Barrett

What does Ross Barrett invest in?
We have not verified a stated sector or stage focus for Ross Barrett at Cancer Focus Fund II, LP (Shreveport). The profile lists the organization, location and investors we track alongside them.
How do I contact Ross Barrett?
Ross Barrett's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Ross Barrett based?
Ross Barrett is based in Shreveport.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Shreveport.

Investors similar to Ross Barrett (20)

Browse related investor lists (1)

Compare Ross Barrett (8)

Investors like Ross Barrett · Full investor directory · Investor access · Company funding database